| 30th Apr 2021 7:00 am |
RNS |
AZN: First quarter 2021 results |
| 26th Apr 2021 7:10 am |
RNS |
Selumetinib recommended for EU approval in NF1 |
| 26th Apr 2021 7:05 am |
RNS |
Tagrisso adjuvant receives positive CHMP opinion |
| 26th Apr 2021 7:00 am |
RNS |
Nirsevimab Phase III trial met primary endpoint |
| 16th Apr 2021 12:00 pm |
RNS |
US clearance of proposed acquisition of Alexion |
| 14th Apr 2021 7:00 am |
RNS |
Tagrisso approved in China in early lung cancer |
| 12th Apr 2021 1:00 pm |
RNS |
Circular and notice of general meeting |
| 12th Apr 2021 7:00 am |
RNS |
Update on Farxiga COVID-19 DARE-19 Phase III trial |
| 1st Apr 2021 3:00 pm |
RNS |
Total Voting Rights |
| 30th Mar 2021 12:15 pm |
RNS |
Notice of AGM |
| 25th Mar 2021 3:00 pm |
RNS |
Director/PDMR Shareholding |
| 25th Mar 2021 7:00 am |
RNS |
AZD1222 US Ph3 primary analysis confirms efficacy |
| 22nd Mar 2021 7:00 am |
RNS |
AstraZeneca US vaccine trial met primary endpoint |
| 16th Mar 2021 7:05 am |
RNS |
Divestment of Viela shareholding completed |
| 16th Mar 2021 7:00 am |
RNS |
US supply agreement for additional AZD7442 doses |
| 9th Mar 2021 3:00 pm |
RNS |
Director/PDMR Shareholding |
| 4th Mar 2021 3:00 pm |
RNS |
Designation of EU home member state |
| 3rd Mar 2021 7:00 am |
RNS |
US court decision favours Symbicort patents |
| 2nd Mar 2021 7:00 am |
RNS |
Further update on roxadustat US regulatory review |
| 1st Mar 2021 3:00 pm |
RNS |
Total Voting Rights |
| 22nd Feb 2021 7:00 am |
RNS |
Voluntary withdrawal Imfinzi US bladder indication |
| 17th Feb 2021 7:00 am |
RNS |
Lynparza: IDMC recommend early analysis of OlympiA |
| 16th Feb 2021 11:15 am |
RNS |
Filing of Form 20-F with SEC |
| 15th Feb 2021 3:00 pm |
RNS |
Director/PDMR Shareholding |
| 15th Feb 2021 11:00 am |
RNS |
Annual Financial Report |
| 11th Feb 2021 7:01 am |
RNS |
AstraZeneca Non-Executive Board changes |
| 11th Feb 2021 7:00 am |
RNS |
AZN: full-year 2020 results |
| 10th Feb 2021 7:00 am |
RNS |
Divestment of Crestor in Europe completed |
| 5th Feb 2021 7:00 am |
RNS |
Update on KESTREL Phase III trial for Imfinzi |
| 4th Feb 2021 7:00 am |
RNS |
Forxiga approved in China for heart failure |
| 1st Feb 2021 3:00 pm |
RNS |
Total Voting Rights |
| 1st Feb 2021 12:15 pm |
RNS |
AstraZeneca agrees to divest Viela shareholding |
| 1st Feb 2021 7:00 am |
RNS |
COVID-19 vaccine authorised for use by the EU |
| 29th Jan 2021 3:16 pm |
RNS |
COVID-19 vaccine receives positive opinion in EU |
| 26th Jan 2021 3:00 pm |
RNS |
Block listing application |
| 26th Jan 2021 7:00 am |
RNS |
Symbicort approved in China for mild asthma |
| 25th Jan 2021 7:05 am |
RNS |
Calquence approved in Japan for CLL |
| 25th Jan 2021 7:00 am |
RNS |
Calquence met primary endpoint against ibrutinib |
| 20th Jan 2021 7:00 am |
RNS |
Enhertu approved in the EU for breast cancer |
| 18th Jan 2021 7:00 am |
RNS |
Enhertu approved in the US for gastric cancer |
